Other

Dataset Information

1K

Cooperative induction of apoptosis in nras mutant melanoma by inhibition of mek and rock


ABSTRACT: Data from ProteomeXchange, PXD ID: PXD000528. Experiment: GM_NKI_NRAS_Phospho_Mix2, file: OR9_20130426_GM_NKI_NRAS_Phospho_Mix2_repl1_ReRunFr10.mzml. Published as part of Pigment Cell Melanoma Res. 2015 Feb 28 . From the Abstract: {{i}} No effective targeted therapy is currently available for NRAS mutant melanoma. Experimental MEK inhibition is rather toxic and has only limited efficacy in clinical trials. At least in part, this is caused by the emergence of drug resistance, which is commonly seen for single agent treatment and shortens clinical responses. Therefore, there is a dire need to identify effective companion drug targets for NRAS mutant melanoma. Here, we show that at concentrations where single drugs had little effect, ROCK inhibitors GSK269962A or Fasudil, in combination with either MEK inhibitor GSK1120212 (Trametinib) or ERK inhibitor SCH772984 cooperatively caused proliferation inhibition and cell death in vitro ... {{/i}}

INSTRUMENT(S): Instrument

ORGANISM(S): Homo_sapiens_viruses, Human

DISEASE(S): Not Available

SUBMITTER: Vogel CJ, et al.  

PROVIDER: GPM32320014056 | GPMDB |

REPOSITORIES: GPMDB

altmetric image

Publications


No effective targeted therapy is currently available for NRAS mutant melanoma. Experimental MEK inhibition is rather toxic and has only limited efficacy in clinical trials. At least in part, this is caused by the emergence of drug resistance, which is commonly seen for single agent treatment and shortens clinical responses. Therefore, there is a dire need to identify effective companion drug targets for NRAS mutant melanoma. Here, we show that at concentrations where single drugs had little effe  ...[more]

Similar Datasets

2014-05-19 | E-GEOD-54532 | biostudies-arrayexpress
2013-06-30 | E-GEOD-44753 | biostudies-arrayexpress
2012-01-19 | E-GEOD-34817 | biostudies-arrayexpress
2012-08-08 | E-GEOD-39984 | biostudies-arrayexpress
2019-03-18 | GSE124059 | GEO
2024-09-02 | BIOMD0000000617 | BioModels
2018-10-24 | PRJEB29344 | EVA
2022-11-01 | GSE206257 | GEO
2022-08-17 | GSE201662 | GEO
2022-08-17 | GSE201661 | GEO